Five local companies willing to buy Sanofi's share  | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
July 13, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JULY 13, 2025
Five local companies willing to buy Sanofi's share 

Economy

Jasim Uddin
14 October, 2019, 03:05 pm
Last modified: 14 October, 2019, 09:08 pm

Related News

  • Sanofi Bangladesh renamed Synovia Pharma
  • Beximco gets central bank nod to acquire Sanofi
  • Sanofi Bangladesh cuts sales staff’s salaries
  • Beximco Pharma buying Sanofi shares
  • Sanofi employees yet to get due benefits

Five local companies willing to buy Sanofi's share 

The French lifesaving drug producing firm has completed its primary discussion with the United Group, Incepta pharmaceuticals Ltd, Akij Group, Partex Group and MGH Group

Jasim Uddin
14 October, 2019, 03:05 pm
Last modified: 14 October, 2019, 09:08 pm
Five local companies willing to buy Sanofi's share 

To sell the share of its plant, the Sanofi Bangladesh Ltd has had discussions with five companies. 

The French lifesaving drug producing firm has completed its primary discussion with the United Group, Incepta pharmaceuticals Ltd, Akij Group, Partex Group and MGH Group.

The Business Standard could reach three of the five company's high officials. One of them said his company is "willing to buy Sanofi's share", while the other two said they are yet to have any discussions with Sanofi. 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

As the Sanofi Sales Force Welfare Association submitted a memorandum to the chair of state-run Bangladesh Chemical Industries Corporation (BCIC), a shareholder of the company, on Monday the issue came to be known.

Preferring anonymity, a BCIC high-official said, the Sanofi has already had talks with some local conglomerates to sell its share. Sanofi Sales Force Welfare Association leaders also confirmed the issue.

When contacted, Managing Director of Sanofi Bangladesh Muin Uddin Mazumder and Head of Communications Farhana Tofail replied through their public relations agency.

"We [Sanofi Bangladesh Ltd] do not want to comment based on rumours."

Sanofi employees have gone for work abstention since last Monday, demanding compensation.

They are suspecting that the company's management will close operations without compensating them.

Things started to go wrong when Ram Prasad Krishna Bhatt was appointed as the chair of the company, Sanofi's Sramik-O-Karmachari Union's President Abdur Razzaque said.

"Sanofi has been operating in the country since 1958. Over the last one and a half years, we have been going through uncertainty," he said in a press conference at Jatiya Press Club on early Sunday.

Muin told them: "the company is preparing to sell its shares to another party, " Abdur claimed.

Razekuzzaman Ratan, worker leader, said the decision of selling the shares will hurt our country.

If Sanofi provides compensation through a third party, many of the employees will become the victims of job cuts.

Employees, as a result, have demanded job security until the issue is resolved, opposing any third party involvement in compensation-related issues, Razekuzzaman said.

"If the management does not meet the demands, employees will form a human chain from October 18," Abdur said, "We will go for a tougher movement this time."

In the first week of August, the company informed the BCIC of its decision to leave Bangladesh.

Sanofi high officials had three meetings with its employees on September 16, 17 and 18, where they advised the employees to submit a compensation proposal.

On September 30, Sanofi employees had submitted a compensation proposal to its country chair Ramparsad and Muin.

On October 2 Sanofi sent a statement to the media, saying that the company has no plan to leave Bangladesh.

The Business Standard has obtained some copies of the meeting minutes and the compensation proposal.

The BCIC, the Ministry of Industries, and the Sanofi Internationa holds19.962, 25.396, and 54.642 percent share of the company, respectively.

Different drugs of the company are popular in Bangladesh – namely Avil and Sefrad.

 

Pharma

Sanofi Bangladesh

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographic: TBS
    Dollar price plummets by Tk2.9 in a week as demand wanes
  • Screengrab blurred
    Mitford murder sparks political storm as BNP on backfoot, Jamaat and NCP pounce
  • Representational image
    Some issues remain unresolved despite progress in 2nd round of US tariff talks: Press Minister Mortoza

MOST VIEWED

  • Representational image
    In addition to 35% tariff, US demands 40% local value addition for 'Made in Bangladesh' goods
  • RAB Director General AKM Shahidur Rahman speaks at the press briefing on a fake bomb threat on Biman Bangladesh flight on Saturday, 12 July 2025. Photo: TBS
    Mother faked bomb threat on Biman flight to stop married son from flying with girlfriend: RAB
  • Screengrab blurred
    Killers bash in head of man with rock, stomp body with perverse pleasure
  • Photo: UNB
    Saima Wazed Putul ‘placed on indefinite leave’ from WHO role amid corruption allegations
  • How tender rules and a lone bidder stall a $2.5b power plant
    How tender rules and a lone bidder stall a $2.5b power plant
  • Bangladesh and US hold tariff talks on 11 July 2025. Photo: CA Press Wing
    Dhaka, Washington yet to agree on 20% of US tariff conditions: BGMEA

Related News

  • Sanofi Bangladesh renamed Synovia Pharma
  • Beximco gets central bank nod to acquire Sanofi
  • Sanofi Bangladesh cuts sales staff’s salaries
  • Beximco Pharma buying Sanofi shares
  • Sanofi employees yet to get due benefits

Features

The 2020 Harrier's Porsche Cayenne coupe-like rear roofline, integrated LED lighting with the Modellista special bodykit all around, and a swanky front grille scream OEM Plus for the sophisticated enthusiast looking for a bigger family car that isn’t boring. PHOTO: Ahbaar Mohammad

2020 Toyota Harrier Hybrid: The Japanese Macan

9h | Wheels
The showroom was launched through a lavish event held there, and in attendance were DHS Motors’ Managing Director Nafees Khundker, CEO Imran Zaman Khan, and GMs Arman Rashid and Farhan Samad. PHOTO: Akif Hamid

GAC inaugurate flagship showroom in Dhaka

10h | Wheels
After India's visa restriction, China's Kunming is drawing Bangladeshi patients

After India's visa restriction, China's Kunming is drawing Bangladeshi patients

1d | Panorama
Photo: Collected/BBC

What Hitler’s tariff policy misfire can teach the modern world

2d | The Big Picture

More Videos from TBS

Why is there a mystery surrounding the death of 'Jalibi' actress Humaira?

Why is there a mystery surrounding the death of 'Jalibi' actress Humaira?

2h | TBS World
Why cockpit audio deepens the mystery of Air India crash

Why cockpit audio deepens the mystery of Air India crash

2h | Others
Housing officer shot in Pallavi for not paying bribe

Housing officer shot in Pallavi for not paying bribe

3h | TBS Today
BNP does not protect criminals like Sheikh Hasina: Rizvi

BNP does not protect criminals like Sheikh Hasina: Rizvi

3h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net